Ertapenem vs ceftriaxone in South Korean patients with pyelonephritis and other complicated urinary tract infections

Trial Profile

Ertapenem vs ceftriaxone in South Korean patients with pyelonephritis and other complicated urinary tract infections

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Jul 2012

At a glance

  • Drugs Ertapenem (Primary) ; Cefixime; Ceftriaxone; Ciprofloxacin
  • Indications Escherichia coli infections; Pyelonephritis; Urinary tract infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Jul 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top